PRAME and non-small cell lung carcinoma: Furthermore, due to the nature of the cancer/testis antigens of PRAME, this protein has been recognized as a potential target for immunotherapy in patients with some types of malignant tumor, such as uveal malignant melanoma and non-small-cell lung cancer [33,34].